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Abstract
Background: Translation of the genome sequence of Plasmodium sp. into biologically relevant information
relies on high through-put genomics technology which includes transcriptome analysis. However, few
studies to date have used this powerful approach to explore transcriptome alterations of P. falciparum
parasites exposed to antimalarial drugs.
Results: The rapid action of artesunate allowed us to study dynamic changes of the parasite transcriptome
in synchronous parasite cultures exposed to the drug for 90 minutes and 3 hours. Developmentally
regulated genes were filtered out, leaving 398 genes which presented altered transcript levels reflecting
drug-exposure. Few genes related to metabolic pathways, most encoded chaperones, transporters,
kinases, Zn-finger proteins, transcription activating proteins, proteins involved in proteasome degradation,
in oxidative stress and in cell cycle regulation. A positive bias was observed for over-expressed genes
presenting a subtelomeric location, allelic polymorphism and encoding proteins with potential export
sequences, which often belonged to subtelomeric multi-gene families. This pointed to the mobilization of
processes shaping the interface between the parasite and its environment. In parallel, pathways were
engaged which could lead to parasite death, such as interference with purine/pyrimidine metabolism, the
mitochondrial electron transport chain, proteasome-dependent protein degradation or the integrity of the
food vacuole.
Conclusion: The high proportion of over-expressed genes encoding proteins exported from the parasite
highlight the importance of extra-parasitic compartments as fields for exploration in drug research which,
to date, has mostly focused on the parasite itself rather than on its intra and extra erythrocytic
environment. Further work is needed to clarify which transcriptome alterations observed reflect a specific
response to overcome artesunate toxicity or more general perturbations on the path to cellular death.
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Background
Efforts at extracting biologically meaningful information
from the genome sequence of Plasmodium sp. are fueled by
the necessity to find new methods of malaria control. Plas-
modium falciparum resistance to most common antimalar-
ials such as chloroquine, sulfadoxine or pyrimethamine,
is now-days widespread, and resistance to other antima-
larials is increasing alarmingly. There is recent evidence
for emerging in vitro resistance to one of the major groups
of drugs, artemisinins [1] and treatment failures to
recently introduced drug combinations including artem-
isinin derivatives [2,3]. Research priorities include the dis-
covery of new drugs, the understanding of drugs' mode of
action and resistance mechanisms. Whatever the drug's
mode of action, a better appraisal of the biological proc-
esses taking place in a parasite dying within an erythrocyte
is needed to uncover additional drug targets and potenti-
ate the effect of existing weapons. Towards reaching such
goals, much hope rests on high through-put technologies
such as DNA microarrays aimed at the study of gene
expression at the genome scale and proteomics. Both
approaches are complementary, and each has its own lim-
itations. Proteomic approaches are complicated by solu-
bility issues, detection of low abundance proteins and
post-translational alterations. Both proteome and tran-
scriptome approaches investigate steady state levels, a net
sum of synthesis and decay of the gene product. Transcrip-
tome studies are limited by the uncertain correlation of
steady state RNA with protein levels. They nevertheless
deliver a comprehensive and sensitive, genome-wide
exploration of expression profiling. This proved invalua-
ble in deciphering the developmental cycle gene expres-
sion patterns in malaria parasites [4,5].
Few studies have shown that the transcriptome of P. falci-
parum can be altered by exposure of the parasite to a drug.
Analysis of the parasite transcriptome under doxycyclin
showed that apicoplast gene expression was deeply
altered [6]. This study is so far the only published example
of a specific transcriptome response to a drug related to
the drug's known target-pathway. No significant changes
of the mRNA levels for enzymes involved in the lipid bio-
synthesis pathway could be evidenced upon exposure for
24–36 hours to the antimalarial choline analog T4, which
targets the inhibition of phosphatidyl choline biosynthe-
sis [7]. In a recent study of the transcriptome of asynchro-
nous P. falciparum cultures under chloroquine pressure
[8], around 600 genes were differentially expressed in
presence of the drug, but only 38 of these were observed
in two different experiments. Such poor reproducibility of
results along with the low expression ratios observed for
these 38 genes was interpreted as reflecting limited reac-
tivity of the parasite transcriptome to environmental stim-
uli and the possible importance of post-transcriptional
gene expression regulation in Plasmodium. However, the
observed discrepancies may relate to different proportions
of developmental stages in the 2 populations explored.
Indeed, parasite maturation stage is an essential variable
to control, as a majority of P. falciparum genes are differ-
entially expressed during the 48 hour erythrocytic cycle
[4]. Such developmentally regulated control of gene
expression hinders the interpretation of results if drug
treatment exerts a retardation effect on the parasite eryth-
rocytic cycle.
We have used here a novel strategy and analysed the alter-
ations of the parasite transcriptome in synchronous para-
site cultures shortly after exposure to a lethal dose of
artesunate, a rapidly acting drug. Artemisinin derivatives
are potent antimalarials that are the cornerstone of cur-
rently recommended drug combination to treat P. falci-
parum malaria [9]. Artemisinins, which are endoperoxide-
containing sesquiterpene lactones are structurally distinct
from all other anti-malarials. Importantly they are the
most rapidly acting antimalarials known to date, which
moreover are active on young as well mature erythrocytic
stages [10]. These unique properties allowed the kinetic
analysis of the events occurring in synchronous cultures of
parasites exposed to a lethal drug concentration at differ-
ent time points along the intraerythrocytic developmental
cycle. We explored the dynamics of transcriptome altera-
tion during the process leading to parasite death in differ-
ent parasite stages. This identified 398 genes with
dynamic transcriptome alterations after exposure to
artesunate.
Results
Choice of experimental design
In order to work with homogeneous parasite populations,
tightly synchronized parasites were used in all experi-
ments, along with an artesunate concentration which irre-
versibly damages 100% of the parasites within 3 hours.
The lethal dose of artesunate, defined here as the minimal
concentration needed for a 3 hour exposure to completely
prevent reinvasion (see "Materials and methods" section),
was 780 nM. Importantly, it corresponds to 100–1000
times the IC50, this dose remains physiological, being in
the range of peak plasma concentration reached in
patients administered artesunate (1300–8400 nM) [11].
Each experiment consisted in an artesunate-free culture
(control) and an artesunate treated culture. For each time
point explored, cDNA from parasites with and without
the drug were labeled with different cyanines, mixed and
hybridized. To analyse dynamic transcriptome altera-
tions, 2 pilot experiments were performed in which RNA
was harvested at 30, 90, 180 minutes and 10 hours of
incubation with the drug. No significant changes in gene
expression could be detected at 30 minutes. In contrast,
after 10 hour incubation time, major transcriptome alter-BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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ations occurred under artesunate, but their analysis was
un-interpretable due to drug-induced massive slowing-
down of parasite development (data not shown). We thus
decided to focus on 2 drug-exposure time, namely 90
minutes and 3 hours after drug addition.
Since artesunate is active on ring stages as well as on older
trophozoite stages, we decided to explore different time
points along the erythrocytic cycle and search for genes
affected at each time point. Therefore, 5 drug treatment
experiments, staggered between 20 hours and 30 hours of
parasite development, were performed for the compari-
son of drug versus no drug at 90 minutes and 3 hours.
Transcript changes under artesunate exposure
We looked for genes displaying similar changes across all
experiments, with the hypothesis that responses to artesu-
nate would not be stage-dependent within the explored
10 hour window of the developmental cycle. The results
of 5 experiments performed at time points staggered
between 20–30 hours post-invasion, were analyzed using
ANOVA with a Holm-Bonferroni method of p-value
adjustment, p < 0.05. This led to a list of genes with simi-
lar ratios of expression (i. e. low variance). From this list,
only genes differentially expressed at 3 hours under
artesunate and not after 3 hours in the absence of the drug
were retained (p = 1). It is important to stress that what we
refer to, for convenience, as over- or under-expression in
fact refers to higher or lower steady state RNA levels.
Due to the high number of microarrays analyzed (32 at 3
hours), power of the statistical analysis was such that
expression log ratios as low as +/- 0.3 could be found for
genes that displayed significant changes by ANOVA [for
distribution of log ratios, see Additional file 1]. This
appeared questionable from a biological standpoint and
we chose to use a cut-off log-ratio of +/- 0.8. This value is
lower than what is usually (and often arbitrarily) chosen
in most transcriptome studies, i.e. +/- 1, but we felt it was
justified given the large amount of data analyzed here and
the low amplitude of fold-changes reported in previous P.
falciparum transcriptome studies [8,12].
In addition, as genes of potential interest could be differ-
entially expressed in the controls but more-so or differ-
ently under artesunate, we needed to identify these and
filter out the developmentally regulated gene expression
profiles. Indeed, the extent to which the drug slowed-
down parasite development is unknown. Thus, different
expression levels in artesunate-exposed vs. control (unex-
posed) cultures could reflect the direct effect of artesunate
together with a possible difference in growth rate/devel-
opmental stage. To identify the developmentally regu-
lated genes in the artesunate-free control culture, the 3
hours RNA was hybridized against the time 0 RNA (3 con-
trol experiments). Even within such a short time window,
81 genes showed differential expression in the control cul-
ture. Filtering-out this potential confounding "slowing-
down effect" established a second list of genes differen-
tially expressed in the artesunate experiments and in the
control experiments, but with significantly different
expression-ratios under these two conditions (p < 0.05)
[see Additional file 2 for the list of differentially expressed
genes].
This resulted in the following: out of the 4703 genes ana-
lyzed, 398 (approx 8.5%) were differentially expressed
after 3 hours in presence of artesunate, 244 over-expressed
(approx 5%) and 154 (approx 3.5%) under-expressed. Of
these 398 genes differentially expressed at 3 hours, 42
showed significant expression changes at 90 minutes, pre-
sumably reflecting an early response to the drug.
Our technically demanding and relatively stringent
approach may have generated false negatives, but we
wanted to be as confident as possible about the list of
genes selected as being differentially expressed. This con-
fidence was supported by the results of qRT-PCR per-
formed with 12 over-expressed and 4 under-expressed
genes, which confirmed the microarray data (Spearman
correlation coefficient: 0.81) [see Additional file 3 for the
comparison between microarray and qRT-PCR results].
Classification of differentially expressed genes
Interesting features were observed in the group of differ-
entially expressed genes. For genes expressed differentially
at 3 hours, there was a strong positive bias in the sub-set
of over-expressed genes towards polymorphic genes
located in sub-telomeric position and carrying PEXEL/
HCT motifs [13] used for export beyond the parasitopho-
rous vacuole into the erythrocyte cytoplasm, or to the red
blood cell membrane/surface (Figure 1). This was deter-
mined after excluding from the analysis the strain-specific
var, stevor and rifin multigene families – which are not
adequately represented in our case since the parasite strain
used differs from 3D7. Concomitant with this positive
bias, there was a negative bias towards conserved genes in
the over-expressed genes. In contrast, the group of under-
expressed genes displayed a positive bias towards con-
served genes and a negative bias towards polymorphic
genes.
Functions (in most cases putative) were assigned to 213 of
the 398 differentially expressed genes [12,14-21] [see
Additional file 2]. Apart from lipid and purine/pyrimidine
metabolism, few genes belonged to the metabolic path-
ways of the parasite (as defined by Ginsburg [16]). Most
genes with altered expression under artesunate pressure
were related to chaperones, transporters, cell cycle,
kinases, Zn finger proteins, transcription activating pro-BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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teins, proteins involved in proteasome degradation, oxi-
dative stress and in cell cycle regulation. A positive bias
towards over-expression could be observed for genes
related to oxidative stress, kinases, transcription associ-
ated proteins and chaperones, and towards under-expres-
sion for genes related to proteasome degradation and
transporters (Figure 2). Slowing down of parasite develop-
ment may be linked to the differential expression of three
genes involved in cell cycle regulation [see Additional file
4]. Two genes were over-expressed, namely PFF1125
encoding a putative RNA binding protein mei2 homo-
logue and PFL1855 encoding a putative cell cycle control
protein, while PFA0345w, encoding a putative centrin,
was under-expressed.
Oxidative stress
Oxidative stress is likely to occur in parasites submitted to
artesunate, whether linked to the direct action of the drug
or to the reduced capacity of the damaged parasite to inac-
tivate free radicals. The antioxidant defense in P. falci-
parum involves both the glutathione and the thioredoxin
Figure 1
Association plots of gene expression with gene chro-
mosomal localization, predicted export sequences 
and polymorphism. A : Bias in gene expression versus 
gene chromosomal localization (subtel = subtelomeric posi-
tion of gene defined as <150 kb from telomere). B: Bias in 
gene expression versus presence of predicted export signals 
[13]. C: Bias in gene expression versus gene polymorphism 
(as defined by presence or absence of non synonymous 
SNPs, from analysis of 3D7, Dd2, HB3, Ghana1 and IT 
genomes). Bar width is proportional to the number of genes 
per category and bar height to the Pearson residuals for an 
independence model. Blue and red colors indicate significant 
bias.
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Differential gene expression under artesunate exposure:  transcript distribution among different gene functional cate- gories Figure 2
Differential gene expression under artesunate expo-
sure: transcript distribution among different gene 
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the 8 different color-coded functional categories as distrib-
uted in the genome represented on the DNA array. "over-
exp." and "under-exp." pie-charts: distribution of over-
expressed and under-expressed genes respectively, among 
the 8 different functional categories. p-value: p-value of chi-
square test of over-expressed gene and under-expressed 
gene compared to the total genes in the genome represented 
on the DNA array.
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system, the relative contribution of each remaining
unknown [22]. Four genes involved in the parasite anti-
oxidant defense [22,23], showed altered transcription
profiles (Table 1) : gamma glutamyl cystein synthetase
and glutathione synthetase (both involved in the glutath-
ione system) were over-expressed. In contrast, the genes
encoding protein disulfide isomerase related protein
(potentially involved in oxidative protein folding, catalyz-
ing both the oxidation and isomerization of disulfides on
nascent polypeptides [24]) and glutathione peroxidase
(shown to rather encode a thioredoxin peroxidase [25]
and thus involved in the thioredoxin system) were under-
expressed. The consecutive action of gamma glutamyl syn-
thetase and glutathione synthetase leads to the produc-
tion of reduced glutathione (GSH), which plays a pivotal
role in the antioxidant defense through maintenance of
the red-ox state of protein -SH moeties, the reduction of
the noxious hydrogen and lipid peroxides and the extru-
sion of toxic compounds (including drugs) [22]. The pre-
dicted outcome of the over-expression of these 2 genes
would be an increased supply of GSH in response to the
oxidative stress induced by artesunate.
Chaperones, protein trafficking and related genes
Genome mining on parasite chaperone analogues has led
to the conclusion that approximately 2% of the P. falci-
parum genes encoded potential or confirmed chaperones
[19]. Chaperone proteins have diverse functions, such as
serving as transcription factors, regulating the cell cycle,
being involved in protein degradation, binding damaged
proteins, protein transport across membranes and protein
folding. As expected in a parasite under severe injury, 13
genes encoding chaperone or chaperone-related proteins
(Table 2) were found up-regulated at 3 hours of artesunate
pressure, among which PfHsp70, PfHsp90 and 6 genes
belonging to the Hsp40 chaperone machinery of P. falci-
parum [20]. The first four were already over-expressed at
90 minutes, along with PFD0080c (a member of the resa-
like DnaJ family) and thus can be considered part of the
early response to the drug. Interestingly, most (9/13),
chaperone-encoding genes up-regulated under artesunate
have potential export signals, suggesting possible export
of their corresponding proteins from the parasite to the
erythrocyte cytoplasm or membrane. Chaperone involve-
ment in trafficking of membrane or exported proteins has
been highlighted in a recent analysis of the parasite chap-
erone network [21]. In particular, analysis of the interac-
tome suggested that a member of the Hsp40 family
(PF14_0700), which interacts with PfHsp70 (PF08_0054)
and PfHsp90 (PF07_0029) could function as a co-chaper-
one in the Hsp90 complex of the parasite to transport
eythrocyte membrane exported proteins such as Antigen
332 (PF11_0507). It is remarkable to note that
PF14_0700, PF08_0054, PF07_0029 and PF11_0507
were all over-expressed under artesunate pressure [see
Additional file 2]. This suggests artesunate-triggered
altered intracellular trafficking, contributing to remode-
ling of the parasitized erythrocyte membrane, a conclu-
sion further substantiated by the observed increased
steady state levels of genes encoding proteins interacting
with the erythrocyte cytoskeleton such as MESA
(PFE0040c), several members of the RESA family and
number of genes carrying PEXEL/HT motifs. Alterations of
the intracellular trafficking is also suggested by altered
transcription profiles of genes such as signal peptidase
(MAL13P1.167) as well as transporters, including
organellar importers (see below).
Transporters
Eleven genes involved in transport were under-expressed
(Table 3). The putative UDP galactose antiporter
(PF11_0141) down-regulated at 3 hours, was the only
transporter found down-regulated at 90 minutes, suggest-
ing that alteration of its transcript levels is an early event.
Four subunits of the vacuolar ATP synthase were under-
expressed. This constitutes one of the few cases of con-
committant regulation of individual components of a spe-
cific machinery or pathway in this study, suggesting that
indeed the activity of the vacuolar ATP synthase was
severely impaired. This enzyme contributes to acidifica-
tion of vacuolar and organelle contents.
Only 4 genes encoding transporters were over-expressed,
amongst which pfmdr1 (PFE1150w), the P-glycoprotein
Table 1: Differentially expressed genes involved in antioxidant defence in artesunate-treated cells
Gene ID Description ART 90 min ART 3 h HS CQ
PFI0925w gamma-glutamylcysteine synthetase 1,41 +
PFE0605c glutathione synthetase 0,94
PFL0595c glutathione peroxidase -0,95
PF11_0352 protein disulfide isomerase related protein -0,89 -
Genes coding for proteins involved in antioxidant defence defined in [23].
Gene ID: identifier as found in PlasmoDB.
Art columns: log ratios of gene expression under artesunate exposure at 90 minutes and 3 hours.
HS column: over (+) or under (-) expression.
Results were compared with transcriptome modifications induced by heat-shock (HS) [12] and chloroquine (CQ) [8].BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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homologue of P. falciparum, which modulates susceptibil-
ity to antimalarial drugs such as quinine, mefloquine and
artemisinins [26-28]. An association has been shown in
the field between sensitivity to arylaminoalcohols or
endoperoxides,  pfmdr1  allelic status and gene copy
number [29], suggesting that an over-expressed functional
Table 2: Differentially expressed chaperone and chaperone-related genes in artesunate-treated cells
Gene ID Description Pexel family ref ART 90 mn ART 3 h HS CQ
PFE1605w DNAJ protein yes resa like/dnaJ 1, 3 1,01
PFD0080c hypothetical protein, conserved in 
P.falciparum
yes resa like 3 1,31 1,82 +
PF10_0378 DnaJ protein, putative yes Hsp40, type III 1, 2, 4 1,33 1,53 +
PFE0040c mature parasite-infected erythrocyte 
surface antigen (MESA) or PfEMP2
yes Hsp40, type IV 2, 4 0,92 1,87
PFA0660w protein with DNAJ domain, dnj1/sis1 
family
yes Hsp40, type II 1, 2, 4 1,01 1,34 +
MAL7P1.7 RESA-like protein yes resa like 3 0,83
PFL0050c hypothetical protein yes resa like 3 0,86
PF07_0029 heat shock protein 86 no hsp90 1 0,9 +
PF07_0030 heat shock protein 86 family protein no Hsp86 family 5 1,63 +
PF08_0054 heat shock 70 kDa protein no hsp70 1 0,88 +
PF11_0034 hypothetical protein yes Hsp40, type IV 1, 2, 4 0,81 +
PFA0675w P. falciparum RESA-like protein with 
DnaJ domain
yes Hsp40, type IV 1, 2, 4 1,96 +
PF14_0700 hypothetical protein, conserved no Hsp40, type III 1, 2, 4 0,81
PF11_0509 ring-infected erythrocyte surface 
antigen putative
yes Hsp40, type IV 1, 2, 4 -1,14
PF13_0102 DNAJ-like Sec63 homologue no Hsp40, type III 1, 2, 4 -1,04
PF11_0216 hypothetical protein no Heat shock factor binding protein 1 6 -0,93 -
PFC0975c PFCYP19, cyclophilin, peptidyl-prolyl 
cis-trans isomerase
no cyclophillin 1 -0,97
Gene ID: identifier as found in PlasmoDB.
Art columns: log ratios of gene expression under artesunate exposure at 90 minutes and 3 hours.
HS column: over (+) or under (-) expression.
Results were compared with transcriptome modifications induced by heat-shock (HS) [12] and chloroquine (CQ) [8].
Chaperone- and chaperone-related genes were defined based on: 1) Acharya et al. [19], 2) Botha et al. [20], 3) resa-like annotation from GeneDB, 
4) genes fitting the HMM profile of DNAJ (PF00226) from Pfam, 5) The Hsp86 family annotation from GeneDB, 6) genes fitting the HMM profile of 
heat shock factor binding protein 1 (PF06825) from Pfam.
Table 3: Differentially expressed transport associated genes in artesunate-treated cells
Gene ID Description ART 90 min ART 3 h HS CQ
PF07_0121 NMD3 protein, putative 0,85
PFB0435c amino acid transporter, putative 0,89
PFE1455w sugar transporter, putative 0,92 +
PFE1150w multidrug resistance protein, Pfmdr1 1,10
PF11_0141 UDP-galactose transporter, putative -0,86 -0,82 -
PFC0725c formate-nitrate transporter, putative -1,16 -
MAL8P1.13 integral membrane protein, conserved/folate-Biopterin transporter -1,13
MAL13P1.206 Na+ -dependent Pi transporter, sodium-dependent phosphate transporter PfPiT -0,90
PF13_0252 nucleoside transporter 1 PfNT1/PfENT1 -1,32
PFL0170w Transporter, major facilitator superfamily -0,86 -
PFE0410w triose or hexose phosphate/phosphate translocator, putative -0,88 -
PF13_0227 vacuolar ATP synthase subunit D, putative -0,92
PF11_0412 Vacuolar ATP synthase subunit F, putative -0,81 -
PF13_0130 vacuolar ATP synthase subunit G, putative -0,82 -
PFE0965c vacuolar ATP synthetase, subunit C putative -0,85
Gene ID: identifier as found in PlasmoDB.
Art columns: log ratios of gene expression under artesunate exposure at 90 minutes and 3 hours.
HS and CQ columns: over (+) or under (-) expression.
Results were compared with transcriptome modifications induced by heat-shock (HS) [12] and chloroquine (CQ) [8].
Genes involved in transport were selected from the pathway maps of Ginsburg [16].BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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pfmdr1 conferred a multidrug resistance like phenotype
[30,31]. Over-expression of pfmdr1  we show to occur
under artesunate pressure may have an impact on suscep-
tibility to the drug(s) associated to artemisinins upon ACT
administration. It also suggests that not only gene copy
number but also gene transcription rates and mRNA sta-
bility should be monitored when exploring mechanisms
of field parasite drug resistance.
Lipid metabolism and the Apicoplast
Eight genes involved in lipid metabolism were differen-
tially expressed (Table 4).
P. falciparum contains an unusually high number of Acyl
CoA synthases (ACS) and binding proteins that might
play a role in fatty acid salvage and transport from the host
cell [32,33]. Amongst the 13 different ACS genes, a non
subtelomeric acyl CoA synthetase gene PFB0685c has
expanded into a family of 9 duplicated genes mainly
located in the subtelomeric regions of the genome and
transcribed during the erythrocytic stage of the parasite. At
least two ACS proteins PfACS1 (PF14_0761) and PfACS3
(PFL2570w) were shown to interact with ankyrin through
their lysine-rich C-terminal domain [34]. Similar
domains are only present in the genes of this family, pos-
sibly targeting these enzymes to the erythrocyte cytoplasm
and/or membrane, an interesting possibility as all the ACS
proteins have a signal peptide but are devoid of the
PEXEL/HT motif. This would contribute to the capacity of
P. falciparum to activate fatty acid scavenged from the
plasma or the erythrocyte membrane, a critical metabolic
function for the survival of the parasite. All 4 ACS genes
over-expressed under artesunate (PFB0685c, PFB695c,
MAL13P1_485 and PF14_0761) belong to this family.
Two acyl-CoA binding protein genes, PF08_0099 and
PF10_0016, were under-expressed. PF14_0664, an Acetyl
CoA carboxylase which generates Malonyl-CoA, likely to
be located in the apicoplast [32], was already found over-
expressed at 90 minutes. Interestingly, the triose phos-
phate transporter located in the outermost membrane of
the apicoplast, PFE0410w, was under-expressed under
artesunate. This transporter, also called PFoTPT, fuels the
apicoplast by providing carbon, reducing power and ATP
[35], but also quite importantly, dihydroxyacetone phos-
phate (DHAP), the precursor needed for isoprenoid and
for phospholipids biosynthesis [36]. Altogether these data
suggest an alteration of fatty acid metabolism both intra-
cellularly and in the apicoplast.
Mitochondrial genes and genes encoding proteins targeted 
to the mitochondrion
The main metabolic function allowed by the active mito-
chondrial electron transport chain maintained by Plasmo-
dium is regeneration of ubiquinone, which is required as
the electron acceptor for dihydroorotate dehydrogenase,
an essential enzyme for pyrimidine biosynthesis [37].
Indeed, 3 important genes involved in mitochondrial
electron transport are under-expressed in presence of
artesunate: 2 subunits of the cytochrome c oxydase
(downstream of the cytochrome bc1 complex inhibited
by atovaquone) coxI and coI and ubiquinol-cytochrome c
reductase hinge protein, PF14_0248 (Table 5). This inter-
ference with the electron transport chain could in turn
affect pyrimidine biosynthesis.
PFC0975c encoding a peptidyl-prolyl cis-trans isomerase
cyclophilin-type belonging to the chaperone network of
the mitochondrial matrix [16] is under-expressed in
response to artesunate. Cyclophilin D/peptidylprolyl iso-
merase activity is a regulator of mitochondrial permeabil-
ity transition, a non selective inner-membrane
permeabilization occuring in response to increased cal-
cium load and redox stress. These 2 conditions are
induced by artesunate. Such a phenomenon can lead to
necrosis through activation of phospholipases, proteases
and nucleases [38].
Table 4: Differentially expressed genes involved in lipid metabolism in artesunate-treated cells
Gene ID Description ART 90 min ART 3 h HS CQ
MAL13P1.485 acyl-coa ligase antigen 0,94
PFB0685c acyl-CoA synthetase, PfACS9 0,83
PFB0695c acyl-CoA synthetase 0,88 1,02 +
PF14_0761 fatty acyl CoA synthetase 1 PfACS1 0,99
PF14_0664 biotin carboxylase subunit of acetyl CoA carboxylase, putative 0,97 1,31 +
PF08_0099 acyl CoA binding protein, putative -0,89
PF10_0016 acyl CoA binding protein, putative -1,04 -
PFE0410w triose or hexose phosphate/phosphate translocator, putative -0,88 -
Gene ID: identifier as found in PlasmoDB.
Art columns: log ratios of gene expression under artesunate exposure at 90 minutes and 3 hours.
HS column: over (+) or under (-) expression.
Results were compared with transcriptome modifications induced by heat-shock (HS) [12] and chloroquine (CQ) [8].
Genes were selected based on [16].BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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Purine/pyrimidine metabolism
In addition to the possibly impaired respiratory chain
interfering with pyrimidine synthesis, expression of other
genes related to purine/pyrimidine biosynthesis was also
modified by artesunate pressure (Table 6): cytidine and
deoxycytidylate deaminase (PF13_0259) hypoxanthine
phophorybosyl transferase (PF10_0121), deoxyuridine
5'triphosphate nucleotidohydrolase (PF11_0282) and
uridine phosphorylase (PFE0660c) are all under-
expressed, while dihydroorotase (PF14_0697) is over-
expressed. Interference with such key metabolic processes
may readily cause parasite death.
Signaling/kinases
The kinome of P. falciparum is atypical, with an atypical
MAP kinase family and a particular R45-FIKK kinase fam-
ily [39].
Fourteen genes encoding kinases, some of which poten-
tially related to signal transduction, were differentially
expressed in presence of artesunate (Table 7). Four of the
11 over-expressed genes were already differentially
expressed at 90 minutes, among which the calcium cal-
modulin dependent protein kinase 2, PfPK2 (PFL1885c).
PfPK2 belongs to the CamK group of P. falciparum kinases,
a family of kinases which can be activated in response to
increased calcium levels, possibly resulting from specific
inhibition of the SERCA PfATPase6 by the drug [40]. The
other 3 genes with increased expression levels at 90 min-
utes were members of the R45-FIKK multigene family
[18,41]. This Apicomplexa-specific kinase gene family is
composed of 20 genes all presenting sub-telomeric posi-
tions, scattered over 11 chromosomes. It has recently been
shown that these kinases localize in different compart-
ments of the infected erythrocyte, some being associated
with the erythrocyte membrane [42]. Under artesunate
pressure, 3 members of the R45-FIKK family were over-
expressed at 90 minutes (PFI0095c, MAL7P1.144 and
PFL0040c) and remained at elevated levels subsequently,
while two additional R45-FIKK Kinases displayed
increased transcript levels at 3 hours, namely PFD1165w
and PF11_0510. All 5 present export motifs. PFD1165w
and PFL0040c are associated with Maurer's clefts, and
PFL0040c with the infected erythrocyte membrane as well
[42].
Transcription associated proteins; zinc finger genes
Transcriptome studies of parasites during the erythrocytic
stages of development have shown that in many cases,
transcription is soon followed by translation, when the
parasite "needs" the considered proteins to further
develop [4]. In contrast, comparison between transcrip-
tomic and proteomic studies have shown the existence of
discrepancies in RNA and protein expression for about
50% of the genes expressed during the erythrocytic devel-
opment [43,44]. This has been clearly confirmed for cer-
tain genes, such as var genes transcribed at the early ring
stage and translated several hours later [45] or a series of
sexual stage proteins the corresponding genes of which are
transcribed long before translation occurs [46]. Genome
mining revealed that relatively few genes (156, 2/3 less
than expected) encode transcription associated proteins
[17]. Six non-Zn finger transcription associated protein
genes, as defined by Coulson [17], were over-expressed
under artesunate, 3 were under-expressed (Table 8). This
relatively low number suggests that transcriptional regula-
tion may not play a major role in gene-expression modu-
lation under drug-induced stress. Altered decay rates may
modulate gene expression in drug-exposed parasites and
contribute to the dynamic changes of mRNA levels
observed here. In this regard, it is worth noting the
recently outlined decreasing RNA decay rate as the para-
site matures. A list of genes encoding putative decay com-
ponents and possibly contributing to such a mechanism
of post-transcriptional regulation in P.falciparum has been
proposed [47]. However, there was no observed effect of
artesunate on expression of these genes.
The low number of TAP identified by Coulson [17] con-
trasted with an over-representation of proteins with Zn
finger motifs [48] potentially involved in regulating RNA
stability. In the present study, 12 genes identified as puta-
Table 5: Differentially expressed genes related to the mitochondrion in artesunate treated cells
Gene ID Description ART 90 min ART 3 h HS CQ
PF08_0054 heat shock 70 kDa protein 0,88 +
coxI putative cytochrome oxidase I -1,07
coI putative cytochrome oxidase I -1,15
PF14_0248 ubiquinol-cytochrome c reductase hinge protein, putative -0,99 -
PFC0975c PFCYP19, cyclophilin, peptidyl-prolyl cis-trans isomerase -0,97
Gene ID: identifier as found in PlasmoDB.
Art columns: log ratios of gene expression under artesunate exposure at 90 minutes and 3 hours.
HS column: over (+) or under (-) expression.
Results were compared with transcriptome modifications induced by heat-shock (HS) [12] and chloroquine (CQ) [8].
Genes were selected based on [16].BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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tive Zn finger bearing proteins were differentially
expressed in the presence of artesunate; 10/12 were over-
expressed, two of which (PFI0470w and PFE1245w)
already at 90 minutes (Table 9).
Discussion
The methodology adopted here allowed us to find repro-
ducible alterations of the transcriptome in P. falciparum
parasites under artesunate pressure. To overcome the
major hurdle of developmentally regulated genes, we
combined the use of a fast acting drug at high dose with
limited incubation time at 5 successive but synchronized
developmental stages. Most observed alterations were of
low amplitude, possibly reflecting particular mechanisms
of gene regulation in malaria parasites. This resulted in a
relatively broad pertubation, that nevertheless was highly
significant and consistent across experiments. We did not
detect altered expression of a single specific metabolic
pathway or of the putative drug target molecules but sev-
eral functionally important groups of genes exhibited
interesting dynamic changes. Within the intrinsic limita-
tions of all transcriptome studies (in which steady-state
RNA levels are studied and not protein quantities, post-
translational modifications or biological activities), the
overall picture that emerges from our current analysis of
the transcriptome changes suggests i) pertubation of the
intracellular trafficking and organisation, including
changes in chaperones, transporters, remodeling the
erythrocyte space beyond the parasitophorous vacuolar
membrane up to the membrane of the infected erythro-
cyte; ii) probable down-phasing of metabolism as
deduced from down-regulation of key enzymes/transport-
ers implicated in purine, pyrimidine and isoprenoid syn-
thesis; iii) an altered mitochondrion; iv) an altered redox
homeostasis and possibly altered protein turnover. In
addition, the transcriptome analysis highlighted numer-
ous genes with unknown function, annotated as coding
for hypothetical proteins [see Additional file 2]. Some dis-
play consistent high and early up-regulation and clearly
deserve further investigation.
Table 6: Differentially expressed genes related to purine/pyrimidine metabolism in artesunate-treated cells
Gene ID Description ART 90 min ART 3 h HS CQ
PF14_0697 dihydroorotase, putative 0,96 0,93
PF13_0259 cytidine and deoxycytidylate deaminase family, putative -1,22
PF10_0121 hypoxanthine phosphoribosyltransferase -1,24
PF11_0282 deoxyuridine 5'-triphosphate nucleotidohydrolase, putative -0,88 -0,95
PFE0660c purine nucleotide phosphorylase, putative -1,07 -1,53
Gene ID: identifier as found in PlasmoDB.
Art columns: log ratios of gene expression under artesunate exposure at 90 minutes and 3 hours.
Results were compared with transcriptome modifications induced by heat-shock (HS) [12] and chloroquine (CQ) [8].
Genes were selected based on [16].
Table 7: Differentially expressed genes encoding kinases in artesunate-treated cells
Gene ID Description Kinase type Name ART 90 min ART 3 h HS CQ
PFL0040c protein kinase, R45/FIKK family R45/FIKK FIKK12 0,88 1,16
MAL7P1.144 protein kinase, R45/FIKK family R45/FIKK FIKK7.1 0,90 1,82
PFI0095c protein kinase, R45/FIKK family R45/FIKK FIKK9.1 0,83 1,28
PF11_0510 protein kinase, R45/FIKK family R45/FIKK FIKK11 0,95
PFD1165w protein kinase, R45/FIKK family R45/FIKK FIKK4.1 1,05
PFL1885c calcium/calmodulin-dependent protein kinase 2, putative kinase PfPK2 1,35 1,21
PFL2280w cyclin g-associated kinase, putative kinase 1,10
PF14_0346 cGMP-dependent protein kinase 1, beta isozyme, putative kinase 1,03
PF11_0242 protein kinase kinase 0,95
PF14_0294 mitogen-activated protein kinase 1, PfMAP1 kinase PfMAP1 1,05
PFD0975w ROI kinase-like protein RIO1 0,90 +
PF11_0377 casein kinase 1, PfCK1 kinase -0,91 +
PF11_0227 serine/threonine protein kinase, puative kinase -0,98
PFB0150c protein kinase, putative kinase -1,05
Gene ID: identifier as found in PlasmoDB.
Art columns: log ratios of gene expression under artesunate exposure at 90 minutes and 3 hours.
CQ column: over (+) or under (-) expression.
Results were compared with transcriptome modifications induced by heat-shock (HS) [12] and chloroquine (CQ) [8].
Kinases were defined as genes fitting the HMM profil kinase PF00069 (update of Ward et al. [39]) and ROI Kinases as genes fiiting the HMM profil 
PF01163. FIKK kinases were defined as described in Schneider and Puijalon [41].BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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The physiological significance of the observed perturba-
tions need to be assessed in future studies. Transcriptome
analysis is the first of a multi-step process, to be followed
by scrutiny of the role of the individual genes identified
here. In particular, it will be essential to establish whether
or not the genes in question are implicated in a rate-limit-
ing process and to analyse the dynamics of the corre-
sponding protein products, including their turnover, post-
translational modifications and cellular localization. An
important question is to clarifiy which transcriptome
alterations are specific to the response to artemisinins and
which are related to a parasite lethally injured, as this has
numerous implications for drug development.
We will discuss the transcriptome data in the frame of
existing knowledge on mechanisms of action of artemisi-
nin derivatives and mechanisms resulting in reduced sus-
ceptibility/resistance. We will next discuss possible
common changes in steady state RNA levels after different
stresses inflicted to the parasite such as exposure to 41°C
or treatment with chloroquine, that can cause parasite
death.
The mechanism of action of artemisinins is debated.
Artemisinin are endoperoxide-containing sesquiterpene
lactones. Fe++-dependent activation of the endoperoxide
bridge is required for the drug to be active [49]. Cleavage
of the endoperoxide moiety forms highly reactive oxyl
radicals that rearrange to more stable carbon-centered rad-
ical intermediates. These in turn form covalent adducts
with parasite products thought to be responsible for a
pleiotropic effect of the drug. Such pleiotropicity may
explain the variety of genes we show here to be affected in
their expression. Recent evidence suggest more specific
Table 8: Differentially expressed genes encoding transcription-associated proteins in artesunate-treated cells
Gene ID Description Pfam annotation ART 90 min ART 3 h HS CQ
PF11_0053 PfSNF2L TAP clustering Nucleosome remodeling::SNF2L 0,82
PF11_0264 DNA-dependent RNA 
polymerase
TAP clustering MITOCHONDRIAL RNA 
POLYMERASE
1,02
PFL0560c minichromosome maintenance 
protein, putative
TAP clustering Minichromosome maintenance 
protein
0,85
PFE0090w hypothetical protein, conserved TAP clustering Histone trancription regulator 0,82
PF11_0297 hypothetical protein TAP clustering CCR4-NOT complex::NOT2 0,86 +
PFE1245w hypothetical protein, conserved PF00642 Zinc finger C-x8-C-x5-C-x3-H type 
(and similar)(PF00642)
1,28 0,91 + +
PF14_0236 hypothetical protein PF00642 Zinc finger C-x8-C-x5-C-x3-H type 
(and similar)(PF00642)
0,89 +
PFC0680w hypothetical protein, conserved PF00642 Zinc finger C-x8-C-x5-C-x3-H type 
(and similar)(PF00642)
1,55 +
PF10_0186 hypothetical protein PF00642 Zinc finger C-x8-C-x5-C-x3-H type 
(and similar)(PF00642)
0,98
MAL13P1.122 hypothetical protein, conserved PF00856 SET domain (PF00856) 0,81
PFI0470w FHA domain protein, putative PF00097 C3HC4 type (RING finger) 
(PF00097)
0,89 1,05
PF10_0046 hypothetical protein PF00097 C3HC4 type (RING finger) 
(PF00097)
1,17
PFF0165c hypothetical protein, conserved PF00097 C3HC4 type (RING finger) 
(PF00097)
0,94
PFL0440c hypothetical protein, conserved PF00097 C3HC4 type (RING finger) 
(PF00097)
0,95
PF11_0315 hypothetical protein TAP clustering APICOPLAST RNA beta, beta, & 
beta subunits
1,64
PFL0145c high mobility group protein PF00505 HMG (high mobility group) box 
(PF00505)
-0,97
MAL13P1.76 TFIIH basal transcription factor 
subunit
TAP clustering TFIIH::p44 -0,83
PF14_0718 hypothetical protein, conserved TAP clustering RNA polymerase II-associated factor 
SOH1
-0,86
Gene ID: identifier as found in PlasmoDB.
Art columns: log ratios of gene expression under artesunate exposure at 90 minutes and 3 hours.
HS and CQ columns: over (+) expression.
Results were compared with transcriptome modifications induced by heat-shock (HS) [12] and chloroquine (CQ) [8].
Genes encoding transcription-associated proteins (TAPs) were selected from the TAP clustering of Coulson et al. [17] and completed with an 
update of genes fitting the following HMM profiles defined by Coulson and colleagues [16] : PF00097, PF00642, PF00096, PF00856, PF00249, 
PF00439, PF00505, PF00628, PF00098, PF00808, PF01753, PF00313, PF00569, PF00643, PF08523, PF02146, PF03366.BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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mechanisms, such as inhibition of specific targets, with
specific inhibition of the P. falciparum SERCA-type Ca++
pump (PfATPase6) [50]. Importantly, field isolates with
markedly reduced in vitro susceptibility to artemether pre-
sented a mutant SERCA-type PfATPase6 [1,51]. Artemisi-
nin has been shown to inhibit the endoplasmic reticulum
– located SERCA-type in Toxoplasma gondii, a related Api-
complexan parasite as well [52]. We did not observe
altered steady state levels of PfATPase6 mRNA at any time
point investigated, indicating that over-expression of this
gene is not part of the parasite response to artesunate.
Ultrastructural alterations of the morphology and their
kinetics are debated as well. Early-stage alterations of the
mitochondrion, the endothelial reticulum and the diges-
tive vacuole were detected in some studies [53] but not
others [54]. Some of the transcriptome alterations may
account for a disorganisation of the digestive vacuole and
the mitochondrion. We observed increased levels of
Pfmdr1  expression concomitant with decreased mRNA
levels of four of the subunits of the H+ vacuolar ATPase,
which is implicated in regulating calcium intracellular
stores of acidic compartments. Downproduction of the H+
vacuolar ATPase and/or alteration of its subunit ratio is
predicted to negatively impact on intracellular calcium
homeostasis. This is most probably on the critical path,
since disruption of calcium homeostasis is central to cel-
lular death, necrosis endophagy and apoptosis. Our tran-
scriptome analysis also shows evidence that artesunate
interferes with expression of genes related to the mito-
chondrion, in most cases by down-regulating their steady
state RNA levels. This calls for additional studies on the
mitochondrial activity after artesunate exposure.
Additional factors are to be considered in light of the tran-
scriptome data, in particular the intracellular partitioning
of the drug. Several studies have demonstrated the selec-
tive uptake of artemisinin derivatives. It has been shown
that artemisinin and dihydroartemisinin, two sesquiter-
pene endoperoxide drugs closely related to artesunate, are
transported by the tubulovesicular network (TVN) formed
within the erythrocyte cytoplasm for nutrient import to
the parasite, and that these drugs disrupted the protein
organization of the TVN [55]. Numerous genes implicated
in intracellular space modelling, trafficking, chaperones
and transport display altered transcription profiles in
artesunate-treated parasites. The markedly bias for such
genes was indeed the most salient observation of our tran-
scriptome study. It is tempting to speculate that this
results in remodelling the intracellular space, including
remodelling of the infected red blood cell membrane and
TVN. This could either be a response aimed at correcting
drug-inflicted damage, preventing further intake of drug
or reflect the dysfunction resulting from such damage.
Protein trafficking is all the more important for parasite
growth and survival that the parasite develops inside a
parasitophorous vacuole within the erythrocyte cyto-
plasm. Interactions between the parasite and the erythro-
cyte are multiple, with an increasing number of parasite
proteins recognized as being involved (reviewed in [56]).
Table 9: Differentially expressed genes encoding proteins with Zn-finger motifs in artesunate-treated cells
Gene ID Description Zn-finger ART 90 min ART 3 h HS CQ
PFE1245w hypothetical protein, conserved Zinc finger C-x8-C-x5-C-x3-H type (PF00642) 1,28 0,91 + +
PF14_0236 hypothetical protein Zinc finger C-x8-C-x5-C-x3-H type (PF00642) 0,89 +
PFC0680w hypothetical protein, conserved Zinc finger C-x8-C-x5-C-x3-H type (PF00642) 1,55 +
PF10_0186 hypothetical protein Zinc finger C-x8-C-x5-C-x3-H type (PF00642) 0,98
MAL13P1.122 hypothetical protein, conserved PHD-finger (IPR001965) 0,81
PF14_0197 hypothetical protein DNL zinc finger (PF05180) 0,87
PFI0470w FHA domain protein, putative C3HC4 type (RING finger) (PF00097) 0,89 1,05
PF10_0046 hypothetical protein C3HC4 type (RING finger) (PF00097) 1,17
PFF0165c hypothetical protein, conserved C3HC4 type (RING finger) (PF00097) 0,94
PFL0440c hypothetical protein, conserved C3HC4 type (RING finger) (PF00097) 0,95
PFB0140w hypothetical protein DHHC zinc finger domain (PF01529) -0,91
MAL13P1.76 TFIIH basal transcription factor subunit TFIIH C1-like domain (PF07975) -0,83
Gene ID: identifier as found in PlasmoDB.
Art columns: log ratios of gene expression under artesunate exposure at 90 minutes and 3 hours.
HS and CQ columns: over (+) expression.
Results were compared with transcriptome modifications induced by heat-shock (HS) [12] and chloroquine (CQ) [8].
Genes containing Zn-motifs were defined as genes fitting the following Zn-finger HMM profiles: B-box zinc finger (PF00643), C3HC zinc finger-like 
(PF07967), C3HC4 type (RING finger) (PF00097), CHY zinc finger (PF05495), CSL zinc finger (PF05207), CW-type Zinc Finger (PF07496), DHHC 
zinc finger domain (PF01529), DNL zinc finger (PF05180), FYVE zinc finger (PF01363), HIT zinc finger (PF04438), MIZ/SP-RING zinc finger 
(PF02891), MYND finger (PF01753), PHD-finger (PF00628), Putative zinc finger motif, C2HC5-type (PF06221), Sec23/Sec24 zinc finger (PF04810), 
SWIM zinc finger (PF04434), TFIIH C1-like domain (PF07975), Tim10/DDP family zinc finger (PF02953), U1 zinc finger (PF06220), Zinc finger C-x8-
C-x5-C-x3-H type (and similar)(PF00642), Zinc finger found in FPG and IleRS (PF06827), Zinc finger, C2H2 type (PF00096), Zinc finger, ZZ type 
(PF00569), ZN-finger, Zn-finger in Ran binding protein and others (PF00641), Zn-finger in ubiquitin-hydrolases and other protein (PF02148), ZPR1 
zinc-finger domain (PF03367), AN1-like Zinc finger (PF01428), C2H2 and C2HC zinc fingers (SSF57667), PHD-finger (IPR001965).BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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Parasite-induced modifications of the red blood cell
through interactions of parasite proteins exported to the
host cell membrane or cytoskeleton play a major role in
parasite survival and virulence, through induction of
infected red cell cytoadhesive properties or decreased
deformability. Altered transcript levels of genes involved
in host cell remodelling and intracellular trafficking have
been reported in parasites lethally damaged by exposure
to febrile temperatures [12]. This suggests that perturbing
intracellular trafficking/remodeling is either on the path
to parasite death or an attempt to overcome a lethal
injury. This also suggests that alterations of intracellular
trafficking by artesunate may be one of the mechanisms
through which the drug can be active on a wide range of
parasite developmental stages.
Analysis of the proteome of artemether-treated P. falci-
parum parasites showed that 30 of the 101 proteins iden-
tified using a MALDI-TOF-MS-based analysis [57],
displayed a greater than three-fold expression level com-
pared to untreated control cultures. Two of the over-
expressed proteins, namely hsp90 (PF07_0029),
PF14_0425 (fructose-biphosphate aldolase) also pre-
sented an increased transcript level in our study. Direct
comparison of both studies is precluded due to limita-
tions such as different sensitivities of the transcriptome
and proteome approaches, more comprehensive coverage
of the expressed products in the transcriptome approach,
different drug exposure protocols and/or transcription/
translation uncoupling, which has been described for
approx 50% of the proteins [43,44].
To put the alterations observed under artesunate in per-
spective with changes induced by unrelated forms of
stress, we analyzed the data in the light of the transcrip-
tome alterations reported after chloroquine [8] treatment
or incubation at 41°C [12], both treatments reported as
having led to parasite death. The transcriptome studies are
not directly comparable, as they were performed under
different experimental conditions (synchronous/asyn-
chronous parasites, glass slide microarrays/Affymetrix
chips) and corresponded to different natures of stress
(rapid acting vs.slow acting). However, identification of a
few genes with altered expression under such different
experimental conditions provides interesting insight.
Such joint analysis is illustrated in the Venn diagram (Fig-
ure 3 see also tables 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 for different
functional groups). There were only 4 genes identified as
differentially expressed under all 3 types of stress:
PFB0095c encoding PfEMP3, PFE1245w, encoding a
putative zinc finger protein, and PF14_0151 encoding a
putative RNA-binding protein and MAL7P1.171 encoding
a hypothetical protein. PfEMP3 and MAL7P1.171 have an
export motif. PfEMP3 is exported to the cytoplasmic face
of the erythrocyte membrane in the mature stages. It asso-
ciates with the erythrocyte cytoskeleton, which it destabi-
lizes [58]. Both PfEMP3 and MAL7P1.171 have been
shown to contribute to trafficking of PfEMP1 [59,60].
Their role in the response to lethal stresses deserves to be
investigated. Characterization of the products encoded by
the remaining 2 common genes certainly warrants partic-
ular attention, as these genes may play a crucial role in the
general response to stress.
The transcriptome of chloroquine-treated and artesunate-
treated parasites shared three additional altered gene pro-
files, namely PFE1455w encoding a putative sugar trans-
porter, PFI0095c and PFL0040c both encoding putative
kinases belonging to the R45-FIKK family. Interestingly
again, the three predicted proteins have an export motif.
However, since there were large inter-experiment varia-
tions in the transcriptome analysis of chloroquine-treated
parasites, commonalities are probably largely underesti-
mated.
Ninety four genes were differentially regulated both under
heat shock and artesunate, 63 over-expressed and 31
under-expressed under both conditions, amongst which
members of the R45-FIKK kinase family, chaperones,
molecules involved in lipid metabolism and number of
hypothetical proteins -including as discussed above
Venn diagram of genes differentially expressed under artesu- nate treatment chloroquine treatment, and heat-shock Figure 3
Venn diagram of genes differentially expressed under 
artesunate treatment chloroquine treatment, and 
heat-shock. Purple circle: 398 genes differentially expressed 
under artesunate (ART). Orange circle: 30 genes differen-
tially expressed under chloroquine (CQ) [8]. Green circle: 
334 genes differentially expressed under heat-shock (HS) 
[12]. ID of genes differentially expressed in ART and CQ, HS 
and CQ, ART, CQ and HS are shown.
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numerous genes coding for proteins with an export motif.
Two of the 5 R45-FIKK kinase genes over-expressed under
artesunate were also over-expressed under chloroquine
pressure [8]. Of the 3 R45/FIKK kinase genes found over-
expressed under heat shock, one was also differentially
expressed under chloroquine. These data suggest that
expression of genes belonging to the R45-FIKK kinase
family reflects the response of the parasite to different
types of environmental modifications and that the para-
site response to different natures of stress may include
common pathways. The same could be said about genes
belonging to 2 other families. Eight of the 13 chaperone/
chaperone-related encoding genes over-expressed under
artesunate were also over-expressed under heat-shock. Of
the 30 Hsp40 type P. falciparum chaperones, 6 were over-
expressed under artesunate, 4 in common with heat-
shock.
Conclusion
The rapid parasiticidal activity of artesunate at high doses
allowed us to study the effects of the drug on the transcrip-
tome of synchronized parasite cultures over a short 3 hour
time window. A positive bias was observed in favor of
subtelomeric localization, polymorphism and presence of
potential export sequences for the subset of upregulated
genes. The corresponding genes, related to protein traf-
ficking, kinases or membrane remodeling, often belong to
multi-gene families [61]. Low amplitude transcript level
alterations were observed, but the large number of
affected genes likely induces substantial perturbations of
the interface between the parasite and its host cellular
environment. Whether these constitute parasite survival
mechanisms or in contrast metabolic cytotoxic alterations
remains to be established. The transcriptome analysis
identified what may represent pathways leading to para-
site death, such as inhibition of purine/pyrimidine metab-
olism, interference with the mitochondrial electron
transport chain, with protein turn-over or with the integ-
rity of the food vacuole and calcium stores.
The high proportion of over-expressed genes encoding
proteins exported from the parasite highlight the impor-
tance of extra-parasitic compartments as fields for explo-
ration in drug research which, to date, has mostly focused
on the parasite within its plasma membrane rather than
within its intra- and extra-erythrocytic environment.
Methods
Parasite cultures
The FCR3 strain (FUP/CB line) [62] of P. falciparum was
used throughout the experiments. Parasites were cultured
using the method described by Trager and Jensen with the
modifications described in Ralph et al. [63]. Cultures were
tightly synchronized by lysing maturing forms through
treatment with 0.3 M Alanine at two successive cycles,
starting 3 hours after rings appeared in the culture [63].
Artesunate treatment was performed the following cycle
(see below).
Drug treatment
Artesunate powder (Arenco, Belgium) was dissolved in
PBS, and the 1 μg/μL aliquoted stock solution was kept at
-20°C. To detect possible loss of activity during storage of
stock solution, the IC50 of the drug was tested periodically.
The IC50 remained stable at around 3.4 nM (2.2–4.6 nM,
SD = 1.2). This also confirmed the artesunate sensitivity of
the FCR3 strain.
Determination of minimal drug concentration irreversi-
bly damaging 100% of the parasites: The lethal artesunate
dose to be used throughout this investigation was deter-
mined using synchronized cultures incubated with
increasing concentrations of artesunate (30-100-300-500-
3000 ng/mL) for 3 hours, washed twice with RPMI and
reincubated at 37°C for 24–30 hours, until next reinva-
sion. Reinvasion was assessed by examining Giemsa
stained blood smears. The lethal dose was the minimal
artesunate concentration needed to prevent 100% of rein-
vasion.
Parasite treatment for studies of the transcriptome: artesu-
nate was added at five different time points during the
cycle following parasite synchronization, staggered
between 20 hours and 30 hours after appearance of the
first rings in the culture (at approximately 20, 22, 26, 28
and 30 hours), while untreated cultures were cultured in
parallel in the absence of drug. Parasites were extracted in
Trizol after 90 minutes and 3 hours of incubation.
Total RNA preparation
Parasite cultures were harvested by centrifugation and
lysed in 5 pellet volumes of Trizol (Gibco) before freezing
at -80°C. Total RNA was prepared from thawed samples
following the manufacturer's instructions. RNA Quality
was assessed with an Agilent 2100 Bioanalyser.
Microarrays and hybridizations
The microarrays used here have been described elsewhere
[63]. Briefly, glass slides were spotted with 7392 70-mer
oligonucleotides originating from the Malaria Oligo Set
(Qiagen-Operon) and custom design oligonucleotides,
covering most of all P. falciparum genes. Of the 5542 iden-
tified  P. falciparum genes, the array covers 4741 genes
(85%). RNA labelling and hybridization were performed
as described [63]. For the comparison of drug versus no
drug at each time point, dye swaps with two technical rep-
licates were performed to compensate dye effect and to
assess technical reproducibility, leading to 4 hybridized
slides per experiment.
In order to determine the genes differentially expressed
between time 0 and 3 hours due to parasite development,BMC Genomics 2008, 9:388 http://www.biomedcentral.com/1471-2164/9/388
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three series of hybridizations were performed with cDNAs
prepared at times 20/23 hours, 23/26 hours and 25/28
hours from the control cultures left without artesunate.
Microarray data were deposited in ArrayExpress [ArrayEx-
press:E-MEXP-1435].
Statistical analysis
All the slides were analyzed pooled together using R [64]
and Bioconductor [65] with the limma package [66,67].
After logarithm transformation of ratio of median of the
intensities (without background substraction) in the two
channels, data were weighted to penalize spots of poor
quality, flagged, or spots for which intensities in the two
channels were close to background (median of intensity
less than median of background plus 2 standard devia-
tions for both Cy3 and Cy5 signals). In a second step, an
intensity-dependent normalization was applied to each
slide (loess), followed by quantile normalization [68]
applied across the arrays to ensure that the log ratios had
the same empirical distribution across arrays and across
channels. After fitting a linear model to the expression
data for each probe using the least square method, com-
parisons of interest were extracted with a contrast matrix.
A moderated t-statistic and a log-odds of differential
expression were computed for each contrast for each gene.
Finally, the raw p-values were adjusted using the Holm
procedure and a type I error rate of 0.05 was applied.
When for a given gene significant log ratios were obtained
for several oligos, the retained log ratio was one with the
maximum absolute value.
Reverse trancription and qPCR
RNA samples were treated with DNAse I (Invitrogen) for
15 minutes at 37°C in presence of RNAseOUT™ inhibitor
(Invitrogen). RNA was reverse transcribed with Super-
script II RT (Invitrogen) using random hexamers with pre-
extension step of 10 minutes at 25°C followed by exten-
sion for 50 minutes at 42°C. Then, cDNA was treated with
RNAse H for 20 minutes at 37°C.
Quantitative real time PCR was performed on cDNA using
an ABI Prism 7900 HT thermal cycler system (Applied
Biosystems) for 40 cycles (95°C for 15 s, 55°C for 15 s
and 60°C for 45 s). Reactions were done in 20 μL volumes
using SYBR Green PCR master Mix (Applied Biosystems)
and 0.5 μM primers in triplicate with 6 concentrations of
cDNA (2500 pg/μL, 625 pg/μL, 156 pg/μL, 39 pg/μL and
10 pg/μL) to assess primer amplification efficiency.
Absence of DNA contamination was check using RNA
sample treated as cDNA without RT (2500 pg/μL).
Primers were designed using eprimer3 [69] [See Addi-
tional file 5 for the primer sequences]. Transcript abun-
dance was compared using mean of ΔΔCt values
calculated for all cDNA dilutions using PFI0425w (puta-
tive transporter) as endogenous normalizer and the con-
trol condition as reference. This gene was chosen as it
remained non differentially expressed in all our experi-
ments and showed very moderate levels of variation in
whole-cycle transcriptome analysis [4].
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Mean log ratio of gene expression in presence/absence of artesunate at 
90 minutes and 3 hours. List is made-up of genes displaying significant 
changes at 3 hour incubation time, across 5 experiments performed at 
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for a given gene significant log ratios were obtained for several oligos, the 
retained log ratio was one with the maximum absolute value. In the 3 
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background: over-expression. Green cell-background: under-expression. 
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